Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.50
Bid: 297.50
Ask: 300.00
Change: -6.00 (-1.98%)
Spread: 2.50 (0.84%)
Open: 313.00
High: 313.50
Low: 296.50
Prev. Close: 302.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

2 Sep 2015 15:12

RNS Number : 8961X
Oxford Biomedica PLC
02 September 2015
 

 

For filings with the FSA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Oxford Biomedica PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Third National Swedish Pension Fund

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

2015-09-01

6. Date on which issuer notified:

2015-09-02

7. Threshold(s) that is/are crossed orreached: vi, vii

3%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0006648157

78,317,715

78,317,715

77,176,027

77,176,027

2.99%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

77,176,027

2.99%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

15. Contact telephone number:

 

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

Third National Swedish Pension Fund

Contact address

(registered office for legal entities)

 

Vasagatan 7, 111 91 Stockholm, Sweden

Phone number & email

 

+468-555 17 100

Other useful information

(at least legal representative for legal persons)

 

Mikael Sedolin

B: Identity of the notifier, if applicable

Full name

 

Sebastian Mossfeldt

Contact address

 

Vasagatan 7, 111 91 Stockholm, Sweden

Phone number & email

 

+468-555 17 162, Sebastian.mossfeldt@ap3.se

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUUASRVRAKRAR
Date   Source Headline
5th Dec 20114:35 pmRNSPrice Monitoring Extension
28th Nov 20117:00 amRNSBlock Listing Six Monthly Return
16th Nov 20117:00 amRNSInterim Management Statement
18th Oct 20117:00 amRNSUS IND Approval for Novel Ocular Product
4th Oct 20114:39 pmRNSTR1 Form
4th Oct 20114:32 pmRNSTR1 Form
31st Aug 20119:00 amRNSTR-1: Notification of Major Interest in Shares
31st Aug 20118:18 amRNSInterim Results- Replacement
31st Aug 20117:00 amRNSInterim Results
4th Aug 20114:35 pmRNSPrice Monitoring Extension
4th Aug 20117:00 amRNSInterim Data from ProSavin® Phase I/II Study
8th Jul 20119:12 amRNSHolding(s) in Company
28th Jun 20117:00 amRNSNotice of Results
7th Jun 20117:00 amRNSResearch Agreement with ImaginAb
26th May 20117:00 amRNSBlock Listing Six Monthly Return
24th May 20117:00 amRNSManagement and Board Changes
19th May 20114:40 pmRNSSecond Price Monitoring Extn
19th May 20114:35 pmRNSPrice Monitoring Extension
18th May 20117:00 amRNSInterim Management Statement
5th May 201112:54 pmRNSAnnual General Meeting and Board Changes
4th May 20117:00 amRNSPfizer License Extension
3rd May 20117:00 amRNSAnnouncement of Data in ProSavin Study
15th Apr 20111:04 pmRNSDirectors' Interest in Shares and Share Options
14th Apr 20114:40 pmRNSSecond Price Monitoring Extn
14th Apr 20114:35 pmRNSPrice Monitoring Extension
4th Apr 201110:28 amRNSAnnual Information Update
31st Mar 20117:12 amRNSAnnual Report and Accounts & AGM Notification
22nd Mar 20117:00 amRNSDirector/PDMR Shareholding
21st Mar 20117:01 amRNSDirectorate Change
21st Mar 20117:00 amRNSStarGen US IND Approval
2nd Mar 20117:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 DEC 2010
31st Jan 20114:40 pmRNSSecond Price Monitoring Extn
31st Jan 20114:35 pmRNSPrice Monitoring Extension
31st Jan 201112:20 pmRNSTotal Voting Rights Update
31st Jan 201112:19 pmRNSNotification of Major Interest in Shares
31st Jan 20117:00 amRNSAcquisition of Manufacturing Facility
20th Jan 20117:00 amRNSNotice of Preliminary Results
12th Jan 20118:20 amRNSHolding in Company
10th Jan 20118:47 amRNSDirectors' Interest in Shares
7th Jan 201111:30 amRNSResult of General Meeting
7th Jan 20117:00 amRNSResult of Open Offer
22nd Dec 20107:00 amRNSProSavin Phase I/II Update
14th Dec 20107:22 amRNSPublication of Prospectus
13th Dec 20104:50 pmRNSRe Proposed Fundraising
13th Dec 20107:47 amRNSProposed Fundraising
26th Nov 20107:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th Nov 20107:00 amRNSUS IND APPROVAL FOR RETINOSTAT
29th Oct 20107:00 amRNSOxford Biomedica PLC Interim Management Statement
26th Oct 20104:35 pmRNSPrice Monitoring Extension
26th Oct 20104:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.